|
Mohan Bala
|
SVP, Chief Development Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
25 Oct 2025 |
250 |
0
|
-
|
|
-
|
Restricted Stock Unit |
|
Mohan Bala
|
SVP, Chief Development Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
25 Oct 2025 |
250 |
2,999
(0%)
|
0%
|
|
0
|
Common Stock |
|
Mohan Bala
|
SVP, Chief Development Officer |
Sale of securities on an exchange or to another person at price $ 9.90 per share. |
25 Oct 2025 |
77 |
2,922
(0%)
|
0%
|
9.9 |
762
|
Common Stock |
|
Martin H. Huber
|
Director, President, CEO |
Sale of securities on an exchange or to another person at price $ 7.31 per share. |
11 Sep 2025 |
2,012 |
9,572
(0%)
|
0%
|
7.3 |
14,708
|
Common Stock |
|
Martin H. Huber
|
Director, President, CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
11 Sep 2025 |
6,670 |
13,340
|
-
|
|
-
|
Restricted Stock Unit |
|
Martin H. Huber
|
Director, President, CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
11 Sep 2025 |
6,670 |
11,584
(0%)
|
0%
|
|
0
|
Common Stock |
|
Anna Protopapas
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 Jun 2025 |
61,500 |
61,500
|
-
|
|
-
|
Stock Option (right to buy) |
|
Kristen M. Hege
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 Jun 2025 |
61,500 |
61,500
|
-
|
|
-
|
Stock Option (right to buy) |
|
Willard H. Dere
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 Jun 2025 |
61,500 |
61,500
|
-
|
|
-
|
Stock Option (right to buy) |
|
David M. Mott
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 Jun 2025 |
61,500 |
61,500
|
-
|
|
-
|
Stock Option (right to buy) |
|
Lawrence M. Alleva
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 Jun 2025 |
61,500 |
61,500
|
-
|
|
-
|
Stock Option (right to buy) |
|
Andrew A. F. Hack
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 Jun 2025 |
61,500 |
61,500
|
-
|
|
-
|
Stock Option (right to buy) |
|
Allene M. Diaz
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 Jun 2025 |
61,500 |
61,500
|
-
|
|
-
|
Stock Option (right to buy) |
|
Anna Protopapas
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Jan 2025 |
21,250 |
176,678
(0%)
|
0%
|
|
0
|
Common Stock |
|
Anna Protopapas
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Jan 2025 |
21,250 |
0
|
-
|
|
-
|
Restricted Stock Unit |
|
Anna Protopapas
|
Director |
Sale of securities on an exchange or to another person at price $ 0.58 per share. |
15 Jan 2025 |
8,637 |
168,041
(0%)
|
0%
|
0.6 |
5,009
|
Common Stock |
|
Alejandra Carvajal
|
SVP, Chief Legal Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Jan 2025 |
12,500 |
83,392
(0%)
|
0%
|
|
0
|
Common Stock |
|
Alejandra Carvajal
|
SVP, Chief Legal Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jan 2025 |
54,167 |
54,167
|
-
|
|
-
|
Restricted Stock Unit |
|
Alejandra Carvajal
|
SVP, Chief Legal Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jan 2025 |
243,750 |
243,750
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Alejandra Carvajal
|
SVP, Chief Legal Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Jan 2025 |
12,500 |
37,500
|
-
|
|
-
|
Restricted Stock Unit |
|
Alejandra Carvajal
|
SVP, Chief Legal Officer |
Sale of securities on an exchange or to another person at price $ 0.58 per share. |
15 Jan 2025 |
5,096 |
78,296
(0%)
|
0%
|
0.6 |
2,956
|
Common Stock |
|
Martin H. Huber
|
Director, President, CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Jan 2025 |
11,062 |
127,389
(0%)
|
0%
|
|
0
|
Common Stock |
|
Martin H. Huber
|
Director, President, CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jan 2025 |
181,400 |
181,400
|
-
|
|
-
|
Restricted Stock Unit |
|
Martin H. Huber
|
Director, President, CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jan 2025 |
816,300 |
816,300
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Martin H. Huber
|
Director, President, CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Jan 2025 |
11,062 |
33,188
|
-
|
|
-
|
Restricted Stock Unit |
|
Martin H. Huber
|
Director, President, CEO |
Sale of securities on an exchange or to another person at price $ 0.58 per share. |
15 Jan 2025 |
4,514 |
122,875
(0%)
|
0%
|
0.6 |
2,618
|
Common Stock |
|
Timothy B. Lowinger
|
SVP, Chief Sci.&Tech. Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jan 2025 |
54,167 |
54,167
|
-
|
|
-
|
Restricted Stock Unit |
|
Timothy B. Lowinger
|
SVP, Chief Sci.&Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Jan 2025 |
7,291 |
253,221
(0%)
|
0%
|
|
0
|
Common Stock |
|
Timothy B. Lowinger
|
SVP, Chief Sci.&Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Jan 2025 |
12,500 |
265,721
(0%)
|
0%
|
|
0
|
Common Stock |
|
Timothy B. Lowinger
|
SVP, Chief Sci.&Tech. Officer |
Sale of securities on an exchange or to another person at price $ 0.58 per share. |
15 Jan 2025 |
8,048 |
257,673
(0%)
|
0%
|
0.6 |
4,668
|
Common Stock |
|
Timothy B. Lowinger
|
SVP, Chief Sci.&Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Jan 2025 |
7,291 |
0
|
-
|
|
-
|
Restricted Stock Unit |
|
Timothy B. Lowinger
|
SVP, Chief Sci.&Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Jan 2025 |
12,500 |
37,500
|
-
|
|
-
|
Restricted Stock Unit |
|
Timothy B. Lowinger
|
SVP, Chief Sci.&Tech. Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jan 2025 |
243,750 |
243,750
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Brian DeSchuytner
|
SVP, COO & CFO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Jan 2025 |
14,583 |
129,863
(0%)
|
0%
|
|
0
|
Common Stock |
|
Brian DeSchuytner
|
SVP, COO & CFO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Jan 2025 |
6,250 |
115,280
(0%)
|
0%
|
|
0
|
Common Stock |
|
Brian DeSchuytner
|
SVP, COO & CFO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jan 2025 |
62,500 |
62,500
|
-
|
|
-
|
Restricted Stock Unit |
|
Brian DeSchuytner
|
SVP, COO & CFO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jan 2025 |
281,250 |
281,250
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Brian DeSchuytner
|
SVP, COO & CFO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Jan 2025 |
14,583 |
43,750
|
-
|
|
-
|
Restricted Stock Unit |
|
Brian DeSchuytner
|
SVP, COO & CFO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Jan 2025 |
6,250 |
0
|
-
|
|
-
|
Restricted Stock Unit |
|
Brian DeSchuytner
|
SVP, COO & CFO |
Sale of securities on an exchange or to another person at price $ 0.58 per share. |
15 Jan 2025 |
8,470 |
121,393
(0%)
|
0%
|
0.6 |
4,913
|
Common Stock |
|
Ashish Mandelia
|
VP, Chief Accounting Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Jan 2025 |
4,519 |
56,907
(0%)
|
0%
|
|
0
|
Common Stock |
|
Ashish Mandelia
|
VP, Chief Accounting Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jan 2025 |
75,000 |
75,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Ashish Mandelia
|
VP, Chief Accounting Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Jan 2025 |
4,166 |
12,501
|
-
|
|
-
|
Restricted Stock Unit |
|
Ashish Mandelia
|
VP, Chief Accounting Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Jan 2025 |
4,519 |
0
|
-
|
|
-
|
Restricted Stock Unit |
|
Ashish Mandelia
|
VP, Chief Accounting Officer |
Sale of securities on an exchange or to another person at price $ 0.58 per share. |
15 Jan 2025 |
3,554 |
57,519
(0%)
|
0%
|
0.6 |
2,061
|
Common Stock |
|
Ashish Mandelia
|
VP, Chief Accounting Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Jan 2025 |
4,166 |
61,073
(0%)
|
0%
|
|
0
|
Common Stock |
|
Ashish Mandelia
|
VP, Chief Accounting Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jan 2025 |
16,667 |
16,667
|
-
|
|
-
|
Restricted Stock Unit |
|
Mohan Bala
|
SVP, Chief Development Officer |
Sale of securities on an exchange or to another person at price $ 0.58 per share. |
15 Jan 2025 |
5,939 |
68,872
(0%)
|
0%
|
0.6 |
3,445
|
Common Stock |
|
Mohan Bala
|
SVP, Chief Development Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Jan 2025 |
14,583 |
43,750
|
-
|
|
-
|
Restricted Stock Unit |
|
Mohan Bala
|
SVP, Chief Development Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jan 2025 |
281,250 |
281,250
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Mohan Bala
|
SVP, Chief Development Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jan 2025 |
62,500 |
62,500
|
-
|
|
-
|
Restricted Stock Unit |
|
Mohan Bala
|
SVP, Chief Development Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Jan 2025 |
14,583 |
74,811
(0%)
|
0%
|
|
0
|
Common Stock |
|
Anna Protopapas
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
14 Jan 2025 |
16,750 |
16,750
|
-
|
|
-
|
Restricted Stock Unit |
|
Anna Protopapas
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
14 Jan 2025 |
16,750 |
161,619
(0%)
|
0%
|
|
0
|
Common Stock |
|
Anna Protopapas
|
Director |
Sale of securities on an exchange or to another person at price $ 0.63 per share. |
14 Jan 2025 |
6,191 |
155,428
(0%)
|
0%
|
0.6 |
3,900
|
Common Stock |
|
Alejandra Carvajal
|
SVP, Chief Legal Officer |
Sale of securities on an exchange or to another person at price $ 0.63 per share. |
14 Jan 2025 |
952 |
70,892
(0%)
|
0%
|
0.6 |
600
|
Common Stock |
|
Alejandra Carvajal
|
SVP, Chief Legal Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
14 Jan 2025 |
2,500 |
71,844
(0%)
|
0%
|
|
0
|
Common Stock |
|
Alejandra Carvajal
|
SVP, Chief Legal Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
14 Jan 2025 |
2,500 |
2,500
|
-
|
|
-
|
Restricted Stock Unit |
|
Timothy B. Lowinger
|
SVP, Chief Sci.&Tech. Officer |
Sale of securities on an exchange or to another person at price $ 0.63 per share. |
14 Jan 2025 |
1,794 |
245,930
(0%)
|
0%
|
0.6 |
1,130
|
Common Stock |
|
Timothy B. Lowinger
|
SVP, Chief Sci.&Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
14 Jan 2025 |
4,792 |
4,791
|
-
|
|
-
|
Restricted Stock Unit |
|
Timothy B. Lowinger
|
SVP, Chief Sci.&Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
14 Jan 2025 |
4,792 |
247,724
(0%)
|
0%
|
|
0
|
Common Stock |
|
Brian DeSchuytner
|
SVP, COO & CFO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
14 Jan 2025 |
6,250 |
111,361
(0%)
|
0%
|
|
0
|
Common Stock |
|
Brian DeSchuytner
|
SVP, COO & CFO |
Sale of securities on an exchange or to another person at price $ 0.63 per share. |
14 Jan 2025 |
2,331 |
109,030
(0%)
|
0%
|
0.6 |
1,469
|
Common Stock |
|
Brian DeSchuytner
|
SVP, COO & CFO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
14 Jan 2025 |
6,250 |
6,250
|
-
|
|
-
|
Restricted Stock Unit |
|
Ashish Mandelia
|
VP, Chief Accounting Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
14 Jan 2025 |
4,783 |
4,783
|
-
|
|
-
|
Restricted Stock Unit |
|
Ashish Mandelia
|
VP, Chief Accounting Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
14 Jan 2025 |
4,783 |
54,179
(0%)
|
0%
|
|
0
|
Common Stock |
|
Ashish Mandelia
|
VP, Chief Accounting Officer |
Sale of securities on an exchange or to another person at price $ 0.63 per share. |
14 Jan 2025 |
1,791 |
52,388
(0%)
|
0%
|
0.6 |
1,128
|
Common Stock |
|
Anna Protopapas
|
Director |
Sale of securities on an exchange or to another person at price $ 0.66 per share. |
13 Jan 2025 |
11,534 |
144,869
(0%)
|
0%
|
0.7 |
7,612
|
Common Stock |
|
Anna Protopapas
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2025 |
31,250 |
62,500
|
-
|
|
-
|
Restricted Stock Unit |
|
Anna Protopapas
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2025 |
31,250 |
156,403
(0%)
|
0%
|
|
0
|
Common Stock |
|
Alejandra Carvajal
|
SVP, Chief Legal Officer |
Sale of securities on an exchange or to another person at price $ 0.66 per share. |
13 Jan 2025 |
3,330 |
69,344
(0%)
|
0%
|
0.7 |
2,198
|
Common Stock |
|
Alejandra Carvajal
|
SVP, Chief Legal Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2025 |
8,958 |
17,917
|
-
|
|
-
|
Restricted Stock Unit |
|
Alejandra Carvajal
|
SVP, Chief Legal Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2025 |
8,958 |
72,674
(0%)
|
0%
|
|
0
|
Common Stock |
|
Timothy B. Lowinger
|
SVP, Chief Sci.&Tech. Officer |
Sale of securities on an exchange or to another person at price $ 0.66 per share. |
13 Jan 2025 |
3,483 |
242,932
(0%)
|
0%
|
0.7 |
2,299
|
Common Stock |
|
Timothy B. Lowinger
|
SVP, Chief Sci.&Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2025 |
9,375 |
18,750
|
-
|
|
-
|
Restricted Stock Unit |
|
Timothy B. Lowinger
|
SVP, Chief Sci.&Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2025 |
9,375 |
246,415
(0%)
|
0%
|
|
0
|
Common Stock |
|
Brian DeSchuytner
|
SVP, COO & CFO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2025 |
10,000 |
108,824
(0%)
|
0%
|
|
0
|
Common Stock |
|
Brian DeSchuytner
|
SVP, COO & CFO |
Sale of securities on an exchange or to another person at price $ 0.66 per share. |
13 Jan 2025 |
3,713 |
105,111
(0%)
|
0%
|
0.7 |
2,451
|
Common Stock |
|
Brian DeSchuytner
|
SVP, COO & CFO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2025 |
10,000 |
20,000
|
-
|
|
-
|
Restricted Stock Unit |
|
Ashish Mandelia
|
VP, Chief Accounting Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2025 |
2,646 |
50,403
(0%)
|
0%
|
|
0
|
Common Stock |
|
Ashish Mandelia
|
VP, Chief Accounting Officer |
Sale of securities on an exchange or to another person at price $ 0.66 per share. |
13 Jan 2025 |
1,007 |
49,396
(0%)
|
0%
|
0.7 |
665
|
Common Stock |
|
Ashish Mandelia
|
VP, Chief Accounting Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2025 |
2,646 |
5,292
|
-
|
|
-
|
Restricted Stock Unit |
|
Mohan Bala
|
SVP, Chief Development Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2025 |
8,750 |
63,481
(0%)
|
0%
|
|
0
|
Common Stock |
|
Mohan Bala
|
SVP, Chief Development Officer |
Sale of securities on an exchange or to another person at price $ 0.66 per share. |
13 Jan 2025 |
3,253 |
60,228
(0%)
|
0%
|
0.7 |
2,147
|
Common Stock |
|
Mohan Bala
|
SVP, Chief Development Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2025 |
8,750 |
17,500
|
-
|
|
-
|
Restricted Stock Unit |
|
Lawrence M. Alleva
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
02 Jan 2025 |
12,521 |
12,521
|
-
|
|
-
|
Stock Option (right to buy) |
|
Mohan Bala
|
SVP, Chief Development Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
25 Oct 2024 |
6,250 |
56,615
(0%)
|
0%
|
|
0
|
Common Stock |
|
Mohan Bala
|
SVP, Chief Development Officer |
Sale of securities on an exchange or to another person at price $ 1.90 per share. |
25 Oct 2024 |
1,884 |
54,731
(0%)
|
0%
|
1.9 |
3,580
|
Common Stock |
|
Mohan Bala
|
SVP, Chief Development Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
25 Oct 2024 |
6,250 |
6,250
|
-
|
|
-
|
Restricted Stock Unit |
|
Lawrence M. Alleva
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Oct 2024 |
9,615 |
9,615
|
-
|
|
-
|
Stock Option (right to buy) |
|
Alejandra Carvajal
|
SVP, Chief Legal Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Oct 2024 |
50,000 |
0
|
-
|
|
-
|
Restricted Stock Unit |
|
Alejandra Carvajal
|
SVP, Chief Legal Officer |
Sale of securities on an exchange or to another person at price $ 1.96 per share. |
01 Oct 2024 |
5,598 |
63,716
(0%)
|
0%
|
2.0 |
10,972
|
Common Stock |
|
Alejandra Carvajal
|
SVP, Chief Legal Officer |
Sale of securities on an exchange or to another person at price $ 2.00 per share. |
01 Oct 2024 |
8,089 |
69,314
(0%)
|
0%
|
2 |
16,178
|
Common Stock |
|
Alejandra Carvajal
|
SVP, Chief Legal Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Oct 2024 |
50,000 |
77,403
(0%)
|
0%
|
|
0
|
Common Stock |
|
Timothy B. Lowinger
|
SVP, Chief Sci.&Tech. Officer |
Sale of securities on an exchange or to another person at price $ 1.96 per share. |
01 Oct 2024 |
5,598 |
235,642
(0%)
|
0%
|
2.0 |
10,972
|
Common Stock |
|
Timothy B. Lowinger
|
SVP, Chief Sci.&Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Oct 2024 |
50,000 |
0
|
-
|
|
-
|
Restricted Stock Unit |
|
Timothy B. Lowinger
|
SVP, Chief Sci.&Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Oct 2024 |
50,000 |
249,329
(0%)
|
0%
|
|
0
|
Common Stock |
|
Timothy B. Lowinger
|
SVP, Chief Sci.&Tech. Officer |
Sale of securities on an exchange or to another person at price $ 2.00 per share. |
01 Oct 2024 |
8,089 |
241,240
(0%)
|
0%
|
2 |
16,178
|
Common Stock |
|
Brian DeSchuytner
|
SVP, COO & CFO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Oct 2024 |
50,000 |
0
|
-
|
|
-
|
Restricted Stock Unit |
|
Brian DeSchuytner
|
SVP, COO & CFO |
Sale of securities on an exchange or to another person at price $ 1.96 per share. |
01 Oct 2024 |
5,598 |
94,824
(0%)
|
0%
|
2.0 |
10,972
|
Common Stock |
|
Brian DeSchuytner
|
SVP, COO & CFO |
Sale of securities on an exchange or to another person at price $ 2.00 per share. |
01 Oct 2024 |
8,089 |
100,422
(0%)
|
0%
|
2 |
16,178
|
Common Stock |
|
Brian DeSchuytner
|
SVP, COO & CFO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Oct 2024 |
50,000 |
108,511
(0%)
|
0%
|
|
0
|
Common Stock |
|
Ashish Mandelia
|
VP, Chief Accounting Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Oct 2024 |
30,000 |
0
|
-
|
|
-
|
Restricted Stock Unit |
|
Ashish Mandelia
|
VP, Chief Accounting Officer |
Sale of securities on an exchange or to another person at price $ 1.96 per share. |
01 Oct 2024 |
3,361 |
47,757
(0%)
|
0%
|
2.0 |
6,588
|
Common Stock |
|
Ashish Mandelia
|
VP, Chief Accounting Officer |
Sale of securities on an exchange or to another person at price $ 2.00 per share. |
01 Oct 2024 |
4,855 |
51,118
(0%)
|
0%
|
2 |
9,710
|
Common Stock |
|
Ashish Mandelia
|
VP, Chief Accounting Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Oct 2024 |
30,000 |
55,973
(0%)
|
0%
|
|
0
|
Common Stock |
|
Mohan Bala
|
SVP, Chief Development Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Oct 2024 |
50,000 |
64,052
(0%)
|
0%
|
|
0
|
Common Stock |
|
Mohan Bala
|
SVP, Chief Development Officer |
Sale of securities on an exchange or to another person at price $ 2.00 per share. |
01 Oct 2024 |
8,089 |
55,963
(0%)
|
0%
|
2 |
16,178
|
Common Stock |
|
Mohan Bala
|
SVP, Chief Development Officer |
Sale of securities on an exchange or to another person at price $ 1.96 per share. |
01 Oct 2024 |
5,598 |
50,365
(0%)
|
0%
|
2.0 |
10,972
|
Common Stock |
|
Mohan Bala
|
SVP, Chief Development Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Oct 2024 |
50,000 |
0
|
-
|
|
-
|
Restricted Stock Unit |
|
Martin H. Huber
|
Director, President, CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
11 Sep 2024 |
166,750 |
166,750
(0%)
|
0%
|
|
0
|
Common Stock |
|
Martin H. Huber
|
Director, President, CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
11 Sep 2024 |
166,750 |
500,250
|
-
|
|
-
|
Restricted Stock Unit |
|
Martin H. Huber
|
Director, President, CEO |
Sale of securities on an exchange or to another person at price $ 1.76 per share. |
11 Sep 2024 |
50,423 |
116,327
(0%)
|
0%
|
1.8 |
88,744
|
Common Stock |
|
Lawrence M. Alleva
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Jul 2024 |
8,972 |
8,972
|
-
|
|
-
|
Stock Option (right to buy) |
|
Anna Protopapas
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Jun 2024 |
55,000 |
55,000
|
-
|
|
-
|
Stock Option (right to buy) |
|
Kristen M. Hege
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Jun 2024 |
55,000 |
55,000
|
-
|
|
-
|
Stock Option (right to buy) |
|
Willard H. Dere
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Jun 2024 |
55,000 |
55,000
|
-
|
|
-
|
Stock Option (right to buy) |
|
David M. Mott
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Jun 2024 |
55,000 |
55,000
|
-
|
|
-
|
Stock Option (right to buy) |
|
Lawrence M. Alleva
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Jun 2024 |
55,000 |
55,000
|
-
|
|
-
|
Stock Option (right to buy) |
|
Andrew A. F. Hack
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Jun 2024 |
55,000 |
55,000
|
-
|
|
-
|
Stock Option (right to buy) |
|
Allene M. Diaz
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Jun 2024 |
55,000 |
55,000
|
-
|
|
-
|
Stock Option (right to buy) |
|
Lawrence M. Alleva
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Apr 2024 |
3,996 |
3,996
|
-
|
|
-
|
Stock Option (right to buy) |
|
H. Huber Martin
|
Director, President, CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jan 2024 |
199,125 |
199,125
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Martin H. Huber
|
Director, President, CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jan 2024 |
44,250 |
44,250
|
-
|
|
-
|
Restricted Stock Unit |
|
B. Lowinger Timothy
|
SVP, Chief Sci.&Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2024 |
4,792 |
194,530
(0%)
|
0%
|
|
0
|
Common Stock |
|
Mandelia Ashish
|
VP, Chief Accounting Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2024 |
4,519 |
27,520
(0%)
|
0%
|
|
0
|
Common Stock |
|
B. Lowinger Timothy
|
SVP, Chief Sci.&Tech. Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Jan 2024 |
50,000 |
50,000
|
-
|
|
-
|
Restricted Stock Unit |
|
Carvajal Alejandra
|
SVP, Chief Legal Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2024 |
2,500 |
5,000
|
-
|
|
-
|
Restricted Stock Unit |
|
Lowinger Timothy B.
|
SVP, Chief Sci.&Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2024 |
7,292 |
7,291
|
-
|
|
-
|
Restricted Stock Unit |
|
Anna Protopapas
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2024 |
16,750 |
115,594
(0%)
|
0%
|
|
0
|
Common Stock |
|
Tushar Misra
|
SVP, Chief Manuf. Officer |
|
13 Jan 2024 |
1,458 |
21,323
(0%)
|
0%
|
|
0
|
Common Stock |
|
Alejandra Carvajal
|
SVP, Chief Legal Officer |
Sale of securities on an exchange or to another person at price $ 2.71 per share. |
13 Jan 2024 |
4,381 |
27,403
(0%)
|
0%
|
2.7 |
11,873
|
Common Stock |
|
Carvajal Alejandra
|
SVP, Chief Legal Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2024 |
8,958 |
29,284
(0%)
|
0%
|
|
0
|
Common Stock |
|
Lowinger B. Timothy
|
SVP, Chief Sci.&Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2024 |
9,375 |
28,125
|
-
|
|
-
|
Restricted Stock Unit |
|
Tushar Misra
|
SVP, Chief Manuf. Officer |
|
13 Jan 2024 |
187,500 |
187,500
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Lowinger B. Timothy
|
SVP, Chief Sci.&Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2024 |
4,792 |
9,583
|
-
|
|
-
|
Restricted Stock Unit |
|
Ashish Mandelia
|
VP, Chief Accounting Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2024 |
4,519 |
4,519
|
-
|
|
-
|
Restricted Stock Unit |
|
Mandelia Ashish
|
VP, Chief Accounting Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2024 |
833 |
28,353
(0%)
|
0%
|
|
0
|
Common Stock |
|
Mandelia Ashish
|
VP, Chief Accounting Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2024 |
4,783 |
23,001
(0%)
|
0%
|
|
0
|
Common Stock |
|
Protopapas Anna
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2024 |
17,708 |
0
|
-
|
|
-
|
Restricted Stock Unit |
|
Timothy B. Lowinger
|
SVP, Chief Sci.&Tech. Officer |
Sale of securities on an exchange or to another person at price $ 2.71 per share. |
13 Jan 2024 |
10,409 |
199,329
(0%)
|
0%
|
2.7 |
28,208
|
Common Stock |
|
Protopapas Anna
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2024 |
31,250 |
98,844
(0%)
|
0%
|
|
0
|
Common Stock |
|
Anna Protopapas
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2024 |
16,750 |
33,500
|
-
|
|
-
|
Restricted Stock Unit |
|
Ashish Mandelia
|
VP, Chief Accounting Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2024 |
4,783 |
9,566
|
-
|
|
-
|
Restricted Stock Unit |
|
Mandelia Ashish
|
VP, Chief Accounting Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2024 |
2,645 |
18,218
(0%)
|
0%
|
|
0
|
Common Stock |
|
Protopapas Anna
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2024 |
21,250 |
136,844
(0%)
|
0%
|
|
0
|
Common Stock |
|
Ashish Mandelia
|
VP, Chief Accounting Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Jan 2024 |
75,000 |
75,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Bala Mohan
|
SVP, Chief Development Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2024 |
8,750 |
26,250
|
-
|
|
-
|
Restricted Stock Unit |
|
Tushar Misra
|
SVP, Chief Manuf. Officer |
|
13 Jan 2024 |
7,083 |
19,865
(0%)
|
0%
|
|
0
|
Common Stock |
|
Bala Mohan
|
SVP, Chief Development Officer |
Sale of securities on an exchange or to another person at price $ 2.71 per share. |
13 Jan 2024 |
3,431 |
14,052
(0%)
|
0%
|
2.7 |
9,298
|
Common Stock |
|
Bala Mohan
|
SVP, Chief Development Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Jan 2024 |
58,333 |
58,333
|
-
|
|
-
|
Restricted Stock Unit |
|
Carvajal Alejandra
|
SVP, Chief Legal Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Jan 2024 |
50,000 |
50,000
|
-
|
|
-
|
Restricted Stock Unit |
|
Alejandra Carvajal
|
SVP, Chief Legal Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Jan 2024 |
225,000 |
225,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Anna Protopapas
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2024 |
17,708 |
154,552
(0%)
|
0%
|
|
0
|
Common Stock |
|
Timothy Lowinger B.
|
SVP, Chief Sci.&Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2024 |
7,916 |
0
|
-
|
|
-
|
Restricted Stock Unit |
|
Mandelia Ashish
|
VP, Chief Accounting Officer |
Sale of securities on an exchange or to another person at price $ 2.71 per share. |
13 Jan 2024 |
5,025 |
23,328
(0%)
|
0%
|
2.7 |
13,618
|
Common Stock |
|
Protopapas Anna
|
Director |
Sale of securities on an exchange or to another person at price $ 2.71 per share. |
13 Jan 2024 |
29,399 |
125,153
(0%)
|
0%
|
2.7 |
79,671
|
Common Stock |
|
B. Timothy Lowinger
|
SVP, Chief Sci.&Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2024 |
7,292 |
201,822
(0%)
|
0%
|
|
0
|
Common Stock |
|
Misra Tushar
|
SVP, Chief Manuf. Officer |
|
13 Jan 2024 |
41,667 |
41,667
|
-
|
|
-
|
Restricted Stock Unit |
|
Anna Protopapas
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2024 |
31,250 |
93,750
|
-
|
|
-
|
Restricted Stock Unit |
|
DeSchuytner Brian
|
SVP, COO & CFO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2024 |
6,250 |
6,250
|
-
|
|
-
|
Restricted Stock Unit |
|
Brian DeSchuytner
|
SVP, COO & CFO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2024 |
10,000 |
30,000
|
-
|
|
-
|
Restricted Stock Unit |
|
Tushar Misra
|
SVP, Chief Manuf. Officer |
|
13 Jan 2024 |
1,458 |
2,916
|
-
|
|
-
|
Restricted Stock Unit |
|
DeSchuytner Brian
|
SVP, COO & CFO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Jan 2024 |
262,500 |
262,500
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Mohan Bala
|
SVP, Chief Development Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Jan 2024 |
262,500 |
262,500
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Brian DeSchuytner
|
SVP, COO & CFO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Jan 2024 |
58,333 |
58,333
|
-
|
|
-
|
Restricted Stock Unit |
|
DeSchuytner Brian
|
SVP, COO & CFO |
Sale of securities on an exchange or to another person at price $ 2.71 per share. |
13 Jan 2024 |
9,327 |
54,511
(0%)
|
0%
|
2.7 |
25,276
|
Common Stock |
|
DeSchuytner Brian
|
SVP, COO & CFO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2024 |
3,958 |
0
|
-
|
|
-
|
Restricted Stock Unit |
|
B. Timothy Lowinger
|
SVP, Chief Sci.&Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2024 |
9,375 |
189,738
(0%)
|
0%
|
|
0
|
Common Stock |
|
Timothy B. Lowinger
|
SVP, Chief Sci.&Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2024 |
7,916 |
209,738
(0%)
|
0%
|
|
0
|
Common Stock |
|
Alejandra Carvajal
|
SVP, Chief Legal Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2024 |
2,500 |
31,784
(0%)
|
0%
|
|
0
|
Common Stock |
|
Mohan Bala
|
SVP, Chief Development Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2024 |
8,750 |
17,483
(0%)
|
0%
|
|
0
|
Common Stock |
|
DeSchuytner Brian
|
SVP, COO & CFO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2024 |
6,250 |
12,500
|
-
|
|
-
|
Restricted Stock Unit |
|
Carvajal Alejandra
|
SVP, Chief Legal Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2024 |
8,958 |
26,875
|
-
|
|
-
|
Restricted Stock Unit |
|
Misra Tushar
|
SVP, Chief Manuf. Officer |
|
13 Jan 2024 |
7,083 |
21,250
|
-
|
|
-
|
Restricted Stock Unit |
|
Mandelia Ashish
|
VP, Chief Accounting Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2024 |
833 |
0
|
-
|
|
-
|
Restricted Stock Unit |
|
Protopapas Anna
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2024 |
21,250 |
21,250
|
-
|
|
-
|
Restricted Stock Unit |
|
Ashish Mandelia
|
VP, Chief Accounting Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Jan 2024 |
16,667 |
16,667
|
-
|
|
-
|
Restricted Stock Unit |
|
Brian DeSchuytner
|
SVP, COO & CFO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2024 |
6,250 |
55,630
(0%)
|
0%
|
|
0
|
Common Stock |
|
Timothy Lowinger B.
|
SVP, Chief Sci.&Tech. Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Jan 2024 |
225,000 |
225,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Brian DeSchuytner
|
SVP, COO & CFO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2024 |
3,958 |
63,838
(0%)
|
0%
|
|
0
|
Common Stock |
|
DeSchuytner Brian
|
SVP, COO & CFO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2024 |
10,000 |
47,380
(0%)
|
0%
|
|
0
|
Common Stock |
|
Brian DeSchuytner
|
SVP, COO & CFO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2024 |
6,250 |
59,880
(0%)
|
0%
|
|
0
|
Common Stock |
|
Mandelia Ashish
|
VP, Chief Accounting Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2024 |
2,645 |
7,938
|
-
|
|
-
|
Restricted Stock Unit |
|
Misra Tushar
|
SVP, Chief Manuf. Officer |
|
13 Jan 2024 |
3,357 |
17,966
(0%)
|
0%
|
2.7 |
9,097
|
Common Stock |
|
Kristen M. Hege
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
02 Jan 2024 |
6,447 |
6,447
|
-
|
|
-
|
Stock Option (right to buy) |
|
Willard Dere H.
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
02 Jan 2024 |
6,112 |
39,182
(0%)
|
0%
|
|
0
|
Common Stock |
|
M. Mott David
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
02 Jan 2024 |
8,810 |
588,694
(1%)
|
0%
|
|
0
|
Common Stock |
|
Alleva Lawrence M.
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
02 Jan 2024 |
7,763 |
7,763
|
-
|
|
-
|
Stock Option (right to buy) |
|
Tushar Misra
|
SVP, Chief Manuf. Officer |
|
16 Aug 2023 |
6,250 |
12,500
|
-
|
|
-
|
Restricted Stock Unit |
|
Tushar Misra
|
SVP, Chief Manuf. Officer |
|
16 Aug 2023 |
1,908 |
11,507
(0%)
|
0%
|
1.2 |
2,251
|
Common Stock |
|
Tushar Misra
|
SVP, Chief Manuf. Officer |
|
16 Aug 2023 |
6,250 |
13,415
(0%)
|
0%
|
|
0
|
Common Stock |
|
Kristen M. Hege
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 Jul 2023 |
3,654 |
3,654
|
-
|
|
-
|
Stock Option (right to buy) |
|
Willard H. Dere
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 Jul 2023 |
4,217 |
22,059
(0%)
|
0%
|
|
0
|
Common Stock |
|
David M. Mott
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 Jul 2023 |
6,079 |
564,011
(1%)
|
0%
|
|
0
|
Common Stock |
|
Lawrence M. Alleva
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 Jul 2023 |
5,391 |
5,391
|
-
|
|
-
|
Stock Option (right to buy) |
|
Martin H. Huber
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 Jul 2023 |
4,477 |
4,477
|
-
|
|
-
|
Stock Option (right to buy) |
|
Kristen M. Hege
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Jun 2023 |
14,467 |
14,467
(0%)
|
0%
|
|
0
|
Common Stock |
|
Kristen M. Hege
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Jun 2023 |
18,355 |
18,355
|
-
|
|
-
|
Stock Option (right to buy) |
|
Willard H. Dere
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Jun 2023 |
14,467 |
17,842
(0%)
|
0%
|
|
0
|
Common Stock |
|
Willard H. Dere
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Jun 2023 |
18,355 |
18,355
|
-
|
|
-
|
Stock Option (right to buy) |
|
David M. Mott
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Jun 2023 |
14,467 |
557,932
(1%)
|
0%
|
|
0
|
Common Stock |
|
David M. Mott
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Jun 2023 |
18,355 |
18,355
|
-
|
|
-
|
Stock Option (right to buy) |
|
Lawrence M. Alleva
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Jun 2023 |
18,355 |
18,355
|
-
|
|
-
|
Stock Option (right to buy) |
|
Lawrence M. Alleva
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Jun 2023 |
14,467 |
14,467
(0%)
|
0%
|
|
0
|
Common Stock |
|
Martin H. Huber
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Jun 2023 |
18,355 |
18,355
|
-
|
|
-
|
Stock Option (right to buy) |
|
Martin H. Huber
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Jun 2023 |
14,467 |
14,467
(0%)
|
0%
|
|
0
|
Common Stock |
|
Andrew A. F. Hack
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Jun 2023 |
14,467 |
14,467
(0%)
|
0%
|
|
0
|
Common Stock |
|
Andrew A. F. Hack
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Jun 2023 |
18,355 |
18,355
|
-
|
|
-
|
Stock Option (right to buy) |
|
Allene M. Diaz
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Jun 2023 |
14,467 |
14,467
(0%)
|
0%
|
|
0
|
Common Stock |
|
Allene M. Diaz
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Jun 2023 |
18,355 |
18,355
|
-
|
|
-
|
Stock Option (right to buy) |
|
Alejandra Carvajal
|
SVP, Chief Legal Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
26 Apr 2023 |
13,250 |
24,270
(0%)
|
0%
|
|
0
|
Common Stock |
|
Alejandra Carvajal
|
SVP, Chief Legal Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
26 Apr 2023 |
13,250 |
0
|
-
|
|
-
|
Restricted stock unit |
|
Alejandra Carvajal
|
SVP, Chief Legal Officer |
Sale of securities on an exchange or to another person at price $ 3.89 per share. |
26 Apr 2023 |
3,944 |
20,326
(0%)
|
0%
|
3.9 |
15,342
|
Common Stock |
|
Kristen M. Hege
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 Apr 2023 |
3,451 |
3,451
|
-
|
|
-
|
Stock Option (right to buy) |
|
Willard H. Dere
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 Apr 2023 |
3,375 |
3,375
(0%)
|
0%
|
|
0
|
Common Stock |
|
David M. Mott
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 Apr 2023 |
4,866 |
543,465
(1%)
|
0%
|
|
0
|
Common Stock |
|
Lawrence M. Alleva
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 Apr 2023 |
4,525 |
4,525
|
-
|
|
-
|
Stock Option (right to buy) |
|
Martin H. Huber
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 Apr 2023 |
3,375 |
3,375
|
-
|
|
-
|
Stock Option (right to buy) |
|
Anna Protopapas
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Jan 2023 |
562,500 |
562,500
|
-
|
|
-
|
Stock option (right to buy) |
|
Anna Protopapas
|
Director, President & CEO |
Gift of securities by or to the insider at price $ 0.00 per share. |
13 Jan 2023 |
240,244 |
10,371
(0%)
|
0%
|
|
0
|
Common Stock |
|
Anna Protopapas
|
Director, President & CEO |
Gift of securities by or to the insider at price $ 0.00 per share. |
13 Jan 2023 |
240,244 |
240,244
(0%)
|
0%
|
|
0
|
Common Stock |
|
Anna Protopapas
|
Director, President & CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2023 |
16,750 |
27,121
(0%)
|
0%
|
|
0
|
Common Stock |
|
Anna Protopapas
|
Director, President & CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2023 |
21,250 |
48,371
(0%)
|
0%
|
|
0
|
Common Stock |
|
Anna Protopapas
|
Director, President & CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2023 |
17,708 |
66,079
(0%)
|
0%
|
|
0
|
Common Stock |
|
Anna Protopapas
|
Director, President & CEO |
Sale of securities on an exchange or to another person at price $ 5.74 per share. |
13 Jan 2023 |
17,346 |
48,733
(0%)
|
0%
|
5.7 |
99,566
|
Common Stock |
|
Anna Protopapas
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Jan 2023 |
125,000 |
125,000
|
-
|
|
-
|
Restricted stock unit |
|
Anna Protopapas
|
Director, President & CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2023 |
16,750 |
50,250
|
-
|
|
-
|
Restricted stock unit |
|
Anna Protopapas
|
Director, President & CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2023 |
21,250 |
42,500
|
-
|
|
-
|
Restricted stock unit |
|
Anna Protopapas
|
Director, President & CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2023 |
17,708 |
17,708
|
-
|
|
-
|
Restricted stock unit |
|
Alejandra Carvajal
|
SVP, Chief Legal Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2023 |
2,500 |
11,802
(0%)
|
0%
|
|
0
|
Common Stock |
|
Alejandra Carvajal
|
SVP, Chief Legal Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Jan 2023 |
161,250 |
161,250
|
-
|
|
-
|
Stock option (right to buy) |
|
Alejandra Carvajal
|
SVP, Chief Legal Officer |
Sale of securities on an exchange or to another person at price $ 5.74 per share. |
13 Jan 2023 |
782 |
11,020
(0%)
|
0%
|
5.7 |
4,489
|
Common Stock |
|
Alejandra Carvajal
|
SVP, Chief Legal Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Jan 2023 |
35,833 |
35,833
|
-
|
|
-
|
Restricted stock unit |
|
Alejandra Carvajal
|
SVP, Chief Legal Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2023 |
2,500 |
7,500
|
-
|
|
-
|
Restricted stock unit |
|
Timothy B. Lowinger
|
SVP, Chief Sci.&Tech. Off. |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Jan 2023 |
168,750 |
168,750
|
-
|
|
-
|
Stock option (right to buy) |
|
Timothy B. Lowinger
|
SVP, Chief Sci.&Tech. Off. |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Jan 2023 |
37,500 |
37,500
|
-
|
|
-
|
Restricted stock unit |
|
Timothy B. Lowinger
|
SVP, Chief Sci.&Tech. Off. |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2023 |
4,792 |
14,375
|
-
|
|
-
|
Restricted stock unit |
|
Timothy B. Lowinger
|
SVP, Chief Sci.&Tech. Off. |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2023 |
7,917 |
7,916
|
-
|
|
-
|
Restricted stock unit |
|
Timothy B. Lowinger
|
SVP, Chief Sci.&Tech. Off. |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2023 |
7,292 |
14,583
|
-
|
|
-
|
Restricted stock unit |
|
Timothy B. Lowinger
|
SVP, Chief Sci.&Tech. Off. |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2023 |
4,792 |
171,387
(0%)
|
0%
|
|
0
|
Common Stock |
|
Timothy B. Lowinger
|
SVP, Chief Sci.&Tech. Off. |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2023 |
7,292 |
178,679
(0%)
|
0%
|
|
0
|
Common Stock |
|
Timothy B. Lowinger
|
SVP, Chief Sci.&Tech. Off. |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2023 |
7,917 |
186,596
(0%)
|
0%
|
|
0
|
Common Stock |
|
Timothy B. Lowinger
|
SVP, Chief Sci.&Tech. Off. |
Sale of securities on an exchange or to another person at price $ 5.74 per share. |
13 Jan 2023 |
6,233 |
180,363
(0%)
|
0%
|
5.7 |
35,777
|
Common Stock |
|
Brian DeSchuytner
|
SVP, Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2023 |
3,958 |
37,912
(0%)
|
0%
|
|
0
|
Common Stock |
|
Brian DeSchuytner
|
SVP, Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2023 |
3,958 |
3,958
|
-
|
|
-
|
Restricted stock unit |
|
Brian DeSchuytner
|
SVP, Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2023 |
6,250 |
12,500
|
-
|
|
-
|
Restricted stock unit |
|
Brian DeSchuytner
|
SVP, Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2023 |
6,250 |
18,750
|
-
|
|
-
|
Restricted stock unit |
|
Brian DeSchuytner
|
SVP, Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Jan 2023 |
40,000 |
40,000
|
-
|
|
-
|
Restricted stock unit |
|
Brian DeSchuytner
|
SVP, Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Jan 2023 |
180,000 |
180,000
|
-
|
|
-
|
Stock option (right to buy) |
|
Brian DeSchuytner
|
SVP, Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 5.74 per share. |
13 Jan 2023 |
5,131 |
32,781
(0%)
|
0%
|
5.7 |
29,452
|
Common Stock |
|
Brian DeSchuytner
|
SVP, Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2023 |
6,250 |
33,954
(0%)
|
0%
|
|
0
|
Common Stock |
|
Brian DeSchuytner
|
SVP, Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2023 |
6,250 |
27,704
(0%)
|
0%
|
|
0
|
Common Stock |
|
Ashish Mandelia
|
VP, Controller |
Sale of securities on an exchange or to another person at price $ 5.74 per share. |
13 Jan 2023 |
3,575 |
13,619
(0%)
|
0%
|
5.7 |
20,521
|
Common Stock |
|
Ashish Mandelia
|
VP, Controller |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Jan 2023 |
47,625 |
47,625
|
-
|
|
-
|
Stock option (right to buy) |
|
Ashish Mandelia
|
VP, Controller |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Jan 2023 |
10,583 |
10,583
|
-
|
|
-
|
Restricted stock unit |
|
Ashish Mandelia
|
VP, Controller |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2023 |
4,784 |
14,349
|
-
|
|
-
|
Restricted stock unit |
|
Ashish Mandelia
|
VP, Controller |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2023 |
4,519 |
9,038
|
-
|
|
-
|
Restricted stock unit |
|
Ashish Mandelia
|
VP, Controller |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2023 |
833 |
833
|
-
|
|
-
|
Restricted stock unit |
|
Ashish Mandelia
|
VP, Controller |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2023 |
4,784 |
11,842
(0%)
|
0%
|
|
0
|
Common Stock |
|
Ashish Mandelia
|
VP, Controller |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2023 |
4,519 |
16,361
(0%)
|
0%
|
|
0
|
Common Stock |
|
Ashish Mandelia
|
VP, Controller |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2023 |
833 |
17,194
(0%)
|
0%
|
|
0
|
Common Stock |
|
Arvin Yang
|
SVP, Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 5.74 per share. |
13 Jan 2023 |
2,209 |
30,821
(0%)
|
0%
|
5.7 |
12,680
|
Common Stock |
|
Arvin Yang
|
SVP, Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2023 |
7,084 |
21,249
|
-
|
|
-
|
Restricted stock unit |
|
Arvin Yang
|
SVP, Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2023 |
7,084 |
33,030
(0%)
|
0%
|
|
0
|
Common Stock |
|
Arvin Yang
|
SVP, Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Jan 2023 |
217,500 |
217,500
|
-
|
|
-
|
Stock option (right to buy) |
|
Arvin Yang
|
SVP, Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Jan 2023 |
48,333 |
48,333
|
-
|
|
-
|
Restricted stock unit |
|
Tushar Misra
|
SVP, CMO |
|
13 Jan 2023 |
1,459 |
6,388
(0%)
|
0%
|
|
0
|
Common Stock |
|
Tushar Misra
|
SVP, CMO |
|
13 Jan 2023 |
1,459 |
4,374
|
-
|
|
-
|
Restricted stock unit |
|
Tushar Misra
|
SVP, CMO |
|
13 Jan 2023 |
28,333 |
28,333
|
-
|
|
-
|
Restricted stock unit |
|
Tushar Misra
|
SVP, CMO |
|
13 Jan 2023 |
127,500 |
127,500
|
-
|
|
-
|
Stock option (right to buy) |
|
Tushar Misra
|
SVP, CMO |
|
13 Jan 2023 |
458 |
5,930
(0%)
|
0%
|
5.7 |
2,629
|
Common Stock |
|
Arvin Yang
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
30 Nov 2022 |
18,500 |
0
|
-
|
|
-
|
Restricted stock unit |
|
Arvin Yang
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
30 Nov 2022 |
18,500 |
31,473
(0%)
|
0%
|
|
0
|
Common Stock |
|
Arvin Yang
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 6.59 per share. |
30 Nov 2022 |
5,527 |
25,946
(0%)
|
0%
|
6.6 |
36,423
|
Common Stock |
|
Tushar Misra
|
Chief Manufacturing Officer |
|
16 Aug 2022 |
6,250 |
18,750
|
-
|
|
-
|
Restricted stock unit |
|
Tushar Misra
|
Chief Manufacturing Officer |
|
16 Aug 2022 |
6,250 |
6,250
(0%)
|
0%
|
|
0
|
Common Stock |
|
Tushar Misra
|
Chief Manufacturing Officer |
|
16 Aug 2022 |
1,879 |
4,371
(0%)
|
0%
|
7.1 |
13,341
|
Common Stock |
|
Kristen M. Hege
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Jun 2022 |
45,000 |
45,000
|
-
|
|
-
|
Stock Option (right to buy) |
|
Willard H. Dere
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Jun 2022 |
45,000 |
45,000
|
-
|
|
-
|
Stock Option (right to buy) |
|
David M. Mott
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Jun 2022 |
45,000 |
45,000
|
-
|
|
-
|
Stock Option (right to buy) |
|
Lawrence M. Alleva
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Jun 2022 |
45,000 |
45,000
|
-
|
|
-
|
Stock Option (right to buy) |
|
Martin H. Huber
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Jun 2022 |
45,000 |
45,000
|
-
|
|
-
|
Stock Option (right to buy) |
|
Andrew A. F. Hack
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Jun 2022 |
45,000 |
45,000
|
-
|
|
-
|
Stock Option (right to buy) |
|
Allene M. Diaz
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Jun 2022 |
45,000 |
45,000
|
-
|
|
-
|
Stock Option (right to buy) |
|
Andrew A. F. Hack
|
Director |
Purchase of securities on an exchange or from another person at price $ 3.20 per share. |
31 May 2022 |
14,760 |
8,663,673
(19%)
|
0%
|
3.2 |
47,182
|
Common Stock |
|
Andrew A. F. Hack
|
Director |
Purchase of securities on an exchange or from another person at price $ 3.28 per share. |
31 May 2022 |
80,759 |
8,648,913
(19%)
|
0%
|
3.3 |
264,776
|
Common Stock |
|
Andrew A. F. Hack
|
Director |
Purchase of securities on an exchange or from another person at price $ 3.17 per share. |
24 May 2022 |
90,155 |
8,493,154
(18%)
|
0%
|
3.2 |
286,242
|
Common Stock |
|
Andrew A. F. Hack
|
Director |
Purchase of securities on an exchange or from another person at price $ 3.19 per share. |
24 May 2022 |
75,000 |
8,568,154
(18%)
|
0%
|
3.2 |
238,943
|
Common Stock |
|
Andrew A. F. Hack
|
Director |
Purchase of securities on an exchange or from another person at price $ 3.29 per share. |
24 May 2022 |
100,000 |
8,402,999
(18%)
|
0%
|
3.3 |
328,990
|
Common Stock |
|
Andrew A. F. Hack
|
Director |
Purchase of securities on an exchange or from another person at price $ 3.49 per share. |
19 May 2022 |
100,000 |
8,187,400
(18%)
|
0%
|
3.5 |
348,620
|
Common Stock |
|
Andrew A. F. Hack
|
Director |
Purchase of securities on an exchange or from another person at price $ 3.35 per share. |
19 May 2022 |
15,599 |
8,302,999
(18%)
|
0%
|
3.3 |
52,247
|
Common Stock |
|
Andrew A. F. Hack
|
Director |
Purchase of securities on an exchange or from another person at price $ 3.46 per share. |
19 May 2022 |
100,000 |
8,287,400
(18%)
|
0%
|
3.5 |
345,570
|
Common Stock |
|
Andrew A. F. Hack
|
Director |
Purchase of securities on an exchange or from another person at price $ 3.18 per share. |
16 May 2022 |
3,440 |
7,876,132
(17%)
|
0%
|
3.2 |
10,952
|
Common Stock |
|
Andrew A. F. Hack
|
Director |
Purchase of securities on an exchange or from another person at price $ 3.10 per share. |
16 May 2022 |
135,292 |
7,872,692
(17%)
|
0%
|
3.1 |
419,446
|
Common Stock |
|
Andrew A. F. Hack
|
Director |
Purchase of securities on an exchange or from another person at price $ 3.35 per share. |
16 May 2022 |
211,268 |
8,087,400
(17%)
|
0%
|
3.3 |
707,262
|
Common Stock |
|
Alejandra Carvajal
|
Chief Legal Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
26 Apr 2022 |
13,250 |
13,250
|
-
|
|
-
|
Restricted stock unit |
|
Alejandra Carvajal
|
Chief Legal Officer |
Sale of securities on an exchange or to another person at price $ 3.69 per share. |
26 Apr 2022 |
3,948 |
9,302
(0%)
|
0%
|
3.7 |
14,568
|
Common Stock |
|
Alejandra Carvajal
|
Chief Legal Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
26 Apr 2022 |
13,250 |
13,250
(0%)
|
0%
|
|
0
|
Common Stock |
|
Andrew A. F. Hack
|
Director |
Purchase of securities on an exchange or from another person at price $ 4.05 per share. |
13 Apr 2022 |
617,284 |
7,737,400
(17%)
|
1%
|
4.0 |
2,500,000
|
Common Stock |
|
Andrew A. F. Hack
|
Director |
Purchase of securities on an exchange or from another person at price $ 4.18 per share. |
12 Apr 2022 |
598,086 |
7,120,116
(15%)
|
1%
|
4.2 |
2,499,880
|
Common Stock |
|
Andrew A. F. Hack
|
Director |
Purchase of securities on an exchange or from another person at price $ 4.42 per share. |
07 Feb 2022 |
1,136,363 |
6,522,030
(14%)
|
2%
|
4.4 |
5,022,724
|
Common Stock |
|
Anna Protopapas
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 Jan 2022 |
67,000 |
67,000
|
-
|
|
-
|
Restricted Stock Units |
|
Anna Protopapas
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 Jan 2022 |
301,450 |
301,450
|
-
|
|
-
|
Stock Option (right to buy) |
|
Anna Protopapas
|
Director, President & CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
14 Jan 2022 |
21,250 |
63,750
|
-
|
|
-
|
Restricted Stock Units |
|
Anna Protopapas
|
Director, President & CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
14 Jan 2022 |
17,708 |
35,416
|
-
|
|
-
|
Restricted Stock Units |
|
Anna Protopapas
|
Director, President & CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
14 Jan 2022 |
38,958 |
322,878
(0%)
|
0%
|
|
-
|
Common Stock |
|
Alejandra Carvajal
|
Chief Legal Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 Jan 2022 |
10,000 |
10,000
|
-
|
|
-
|
Restricted Stock Units |
|
Alejandra Carvajal
|
Chief Legal Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 Jan 2022 |
45,000 |
45,000
|
-
|
|
-
|
Stock Option (right to buy) |
|
Timothy B. Lowinger
|
Chief Science & Tech Off. |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
14 Jan 2022 |
7,292 |
21,875
|
-
|
|
-
|
Restricted Stock Units |
|
Timothy B. Lowinger
|
Chief Science & Tech Off. |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
14 Jan 2022 |
15,209 |
135,975
(0%)
|
0%
|
|
-
|
Common Stock |
|
Timothy B. Lowinger
|
Chief Science & Tech Off. |
Sale of securities on an exchange or to another person at price $ 5.92 per share. |
14 Jan 2022 |
4,741 |
131,234
(0%)
|
0%
|
5.9 |
28,067
|
Common Stock |
|
Timothy B. Lowinger
|
Chief Science & Tech Off. |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
14 Jan 2022 |
7,917 |
15,833
|
-
|
|
-
|
Restricted Stock Units |
|
Timothy B. Lowinger
|
Chief Science & Tech Off. |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 Jan 2022 |
86,250 |
86,250
|
-
|
|
-
|
Stock Option (right to buy) |
|
Timothy B. Lowinger
|
Chief Science & Tech Off. |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 Jan 2022 |
19,167 |
19,167
|
-
|
|
-
|
Restricted Stock Units |
|
Brian DeSchuytner
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
14 Jan 2022 |
6,250 |
18,750
|
-
|
|
-
|
Restricted Stock Units |
|
Brian DeSchuytner
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
14 Jan 2022 |
3,958 |
7,916
|
-
|
|
-
|
Restricted Stock Units |
|
Brian DeSchuytner
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
14 Jan 2022 |
10,208 |
17,573
(0%)
|
0%
|
|
-
|
Common Stock |
|
Brian DeSchuytner
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 Jan 2022 |
25,000 |
25,000
|
-
|
|
-
|
Restricted Stock Units |
|
Brian DeSchuytner
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 Jan 2022 |
112,500 |
112,500
|
-
|
|
-
|
Stock Option (right to buy) |
|
Ashish Mandelia
|
VP, Controller |
Sale of securities on an exchange or to another person at price $ 5.92 per share. |
14 Jan 2022 |
1,982 |
3,371
(0%)
|
0%
|
5.9 |
11,733
|
Common Stock |
|
Ashish Mandelia
|
VP, Controller |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
14 Jan 2022 |
5,353 |
5,353
(0%)
|
0%
|
|
-
|
Common Stock |
|
Ashish Mandelia
|
VP, Controller |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 Jan 2022 |
19,133 |
19,133
|
-
|
|
-
|
Restricted Stock Units |
|
Ashish Mandelia
|
VP, Controller |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 Jan 2022 |
28,700 |
28,700
|
-
|
|
-
|
Stock Option (right to buy) |
|
Ashish Mandelia
|
VP, Controller |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
14 Jan 2022 |
4,520 |
13,557
|
-
|
|
-
|
Restricted Stock Units |
|
Ashish Mandelia
|
VP, Controller |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
14 Jan 2022 |
833 |
1,666
|
-
|
|
-
|
Restricted Stock Units |
|
Arvin Yang
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 Jan 2022 |
28,333 |
28,333
|
-
|
|
-
|
Restricted Stock Units |
|
Arvin Yang
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 Jan 2022 |
127,500 |
127,500
|
-
|
|
-
|
Stock Option (right to buy) |
|
Tushar Misra
|
Chief Manufacturing Officer |
|
14 Jan 2022 |
26,250 |
26,250
|
-
|
|
-
|
Stock Option (right to buy) |
|
Tushar Misra
|
Chief Manufacturing Officer |
|
14 Jan 2022 |
5,833 |
5,833
|
-
|
|
-
|
Restricted Stock Units |
|
Kristen M. Hege
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 Jan 2022 |
10,416 |
10,416
|
-
|
|
-
|
Stock Option (right to buy) |
|
Willard H. Dere
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 Jan 2022 |
12,847 |
12,847
|
-
|
|
-
|
Stock Option (right to buy) |
|
David M. Mott
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 Jan 2022 |
18,518 |
18,518
|
-
|
|
-
|
Stock Option (right to buy) |
|
Lawrence M. Alleva
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 Jan 2022 |
13,657 |
13,657
|
-
|
|
-
|
Stock Option (right to buy) |
|
Martin H. Huber
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 Jan 2022 |
10,185 |
10,185
|
-
|
|
-
|
Stock Option (right to buy) |
|
Andrew A. F. Hack
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 Jan 2022 |
10,995 |
10,995
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Allene M. Diaz
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 Jan 2022 |
10,416 |
10,416
|
-
|
|
-
|
Stock Option (right to buy) |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.40 per share. |
20 Dec 2021 |
45,593 |
120,766
(0%)
|
0%
|
1.4 |
63,830
|
Common Stock |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
20 Dec 2021 |
45,593 |
0
|
-
|
|
-
|
Stock Option (right to buy) |
|
Arvin Yang
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
30 Nov 2021 |
18,500 |
18,500
|
-
|
|
-
|
Restricted Stock Units |
|
Arvin Yang
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 6.81 per share. |
30 Nov 2021 |
5,527 |
12,973
(0%)
|
0%
|
6.8 |
37,639
|
Common Stock |
|
Arvin Yang
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
30 Nov 2021 |
18,500 |
18,500
(0%)
|
0%
|
|
-
|
Common Stock |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Sale of securities on an exchange or to another person at price $ 11.01 per share. |
20 Aug 2021 |
2,216 |
75,173
(0%)
|
0%
|
11.0 |
24,398
|
Common Stock |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
20 Aug 2021 |
2,216 |
77,195
|
-
|
|
-
|
Stock Option (right to buy) |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.16 per share. |
20 Aug 2021 |
2,216 |
77,389
(0%)
|
0%
|
6.2 |
13,651
|
Common Stock |
|
Tushar Misra
|
Chief Manufacturing Officer |
|
16 Aug 2021 |
25,000 |
25,000
|
-
|
|
-
|
Restricted stock unit |
|
Tushar Misra
|
Chief Manufacturing Officer |
|
16 Aug 2021 |
112,500 |
112,500
|
-
|
|
-
|
Stock Option (right to buy) |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Sale of securities on an exchange or to another person at price $ 12.11 per share. |
20 Jul 2021 |
2,227 |
75,173
(0%)
|
0%
|
12.1 |
26,969
|
Common Stock |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
20 Jul 2021 |
2,227 |
79,411
|
-
|
|
-
|
Stock Option (right to buy) |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.16 per share. |
20 Jul 2021 |
2,227 |
77,400
(0%)
|
0%
|
6.2 |
13,718
|
Common Stock |
|
Anna Protopapas
|
Director, President & CEO |
Sale of securities on an exchange or to another person at price $ 12.47 per share. |
15 Jul 2021 |
20,043 |
304,879
(0%)
|
0%
|
12.5 |
249,936
|
Common Stock |
|
Anna Protopapas
|
Director, President & CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Jul 2021 |
100,000 |
0
|
-
|
|
-
|
Restricted Stock Units |
|
Anna Protopapas
|
Director, President & CEO |
Sale of securities on an exchange or to another person at price $ 12.02 per share. |
15 Jul 2021 |
21,901 |
282,978
(0%)
|
0%
|
12.0 |
263,250
|
Common Stock |
|
Anna Protopapas
|
Director, President & CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Jul 2021 |
100,000 |
324,922
(0%)
|
0%
|
|
-
|
Common Stock |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Jul 2021 |
40,000 |
91,444
(0%)
|
0%
|
|
-
|
Common Stock |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Jul 2021 |
40,000 |
0
|
-
|
|
-
|
Restricted Stock Units |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Sale of securities on an exchange or to another person at price $ 12.02 per share. |
15 Jul 2021 |
8,496 |
75,173
(0%)
|
0%
|
12.0 |
102,122
|
Common Stock |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Sale of securities on an exchange or to another person at price $ 12.47 per share. |
15 Jul 2021 |
7,775 |
83,669
(0%)
|
0%
|
12.5 |
96,954
|
Common Stock |
|
Michael Kaufman
|
Chief Manufacturing Officer |
Sale of securities on an exchange or to another person at price $ 12.47 per share. |
15 Jul 2021 |
5,776 |
38,934
(0%)
|
0%
|
12.5 |
72,027
|
Common Stock |
|
Michael Kaufman
|
Chief Manufacturing Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Jul 2021 |
40,000 |
0
|
-
|
|
-
|
Restricted Stock Units |
|
Michael Kaufman
|
Chief Manufacturing Officer |
Sale of securities on an exchange or to another person at price $ 12.02 per share. |
15 Jul 2021 |
6,312 |
32,622
(0%)
|
0%
|
12.0 |
75,870
|
Common Stock |
|
Michael Kaufman
|
Chief Manufacturing Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Jul 2021 |
40,000 |
44,710
(0%)
|
0%
|
|
-
|
Common Stock |
|
Timothy B. Lowinger
|
CS & Technology Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
08 Jul 2021 |
20,000 |
45,593
|
-
|
|
-
|
Stock Option (right to buy) |
|
Timothy B. Lowinger
|
CS & Technology Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.40 per share. |
08 Jul 2021 |
20,000 |
51,444
(0%)
|
0%
|
1.4 |
28,000
|
Common Stock |
|
Timothy B. Lowinger
|
CS & Technology Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Jul 2021 |
1,877 |
10,303
|
-
|
|
-
|
Stock Option (right to buy) |
|
Timothy B. Lowinger
|
CS & Technology Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Jul 2021 |
9 |
81,638
|
-
|
|
-
|
Stock Option (right to buy) |
|
Timothy B. Lowinger
|
CS & Technology Officer |
Sale of securities on an exchange or to another person at price $ 13.60 per share. |
01 Jul 2021 |
1,886 |
31,444
(0%)
|
0%
|
13.6 |
25,650
|
Common Stock |
|
Timothy B. Lowinger
|
CS & Technology Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.11 per share. |
01 Jul 2021 |
9 |
33,330
(0%)
|
0%
|
6.1 |
55
|
Common Stock |
|
Timothy B. Lowinger
|
CS & Technology Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.51 per share. |
01 Jul 2021 |
1,877 |
33,321
(0%)
|
0%
|
3.5 |
6,588
|
Common Stock |
|
Ashish Mandelia
|
VP, Controller |
Sale of securities on an exchange or to another person at price $ 13.60 per share. |
01 Jul 2021 |
942 |
0
(0%)
|
0%
|
13.6 |
12,811
|
Common Stock |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
21 Jun 2021 |
2,218 |
81,647
|
-
|
|
-
|
Stock Option (right to buy) |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.50 per share. |
21 Jun 2021 |
2 |
31,446
(0%)
|
0%
|
3.5 |
7
|
Common Stock |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Sale of securities on an exchange or to another person at price $ 13.78 per share. |
21 Jun 2021 |
2,218 |
31,444
(0%)
|
0%
|
13.8 |
30,564
|
Common Stock |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.16 per share. |
21 Jun 2021 |
2,218 |
33,662
(0%)
|
0%
|
6.2 |
13,663
|
Common Stock |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Sale of securities on an exchange or to another person at price $ 14.00 per share. |
21 Jun 2021 |
2 |
31,444
(0%)
|
0%
|
14 |
28
|
Common Stock |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
21 Jun 2021 |
2 |
12,180
|
-
|
|
-
|
Stock Option (right to buy) |
|
Kristen M. Hege
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Jun 2021 |
25,050 |
25,050
|
-
|
|
-
|
Stock Option (right to buy) |
|
Willard H. Dere
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Jun 2021 |
25,050 |
25,050
|
-
|
|
-
|
Stock Option (right to buy) |
|
David M. Mott
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Jun 2021 |
25,050 |
25,050
|
-
|
|
-
|
Stock Option (right to buy) |
|
Lawrence M. Alleva
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Jun 2021 |
25,050 |
25,050
|
-
|
|
-
|
Stock Option (right to buy) |
|
Martin H. Huber
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Jun 2021 |
25,050 |
25,050
|
-
|
|
-
|
Stock Option (right to buy) |
|
Andrew A. F. Hack
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Jun 2021 |
25,050 |
25,050
|
-
|
|
-
|
Stock Option (right to buy) |
|
Lawrence M. Alleva
|
Director |
Purchase of securities on an exchange or from another person at price $ 14.38 per share. |
01 Jun 2021 |
1,035 |
2,120
(0%)
|
0%
|
14.4 |
14,883
|
Common Stock |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Sale of securities on an exchange or to another person at price $ 14.10 per share. |
20 May 2021 |
1,875 |
31,444
(0%)
|
0%
|
14.1 |
26,438
|
Common Stock |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
20 May 2021 |
2,227 |
83,865
|
-
|
|
-
|
Stock Option (right to buy) |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
20 May 2021 |
1,875 |
12,182
|
-
|
|
-
|
Stock Option (right to buy) |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Sale of securities on an exchange or to another person at price $ 14.10 per share. |
20 May 2021 |
2,227 |
31,444
(0%)
|
0%
|
14.1 |
31,401
|
Common Stock |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.16 per share. |
20 May 2021 |
2,227 |
33,671
(0%)
|
0%
|
6.2 |
13,718
|
Common Stock |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.51 per share. |
20 May 2021 |
1,875 |
33,319
(0%)
|
0%
|
3.5 |
6,581
|
Common Stock |
|
Alejandra Carvajal
|
Chief Legal Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Apr 2021 |
26,500 |
25,000
|
-
|
|
-
|
Restricted stock unit |
|
Alejandra Carvajal
|
Chief Legal Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Apr 2021 |
112,500 |
112,500
|
-
|
|
-
|
Stock Option (right to buy) |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Sale of securities on an exchange or to another person at price $ 15.91 per share. |
20 Apr 2021 |
2,227 |
31,444
(0%)
|
0%
|
15.9 |
35,432
|
Common Stock |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Sale of securities on an exchange or to another person at price $ 15.91 per share. |
20 Apr 2021 |
1,875 |
31,444
(0%)
|
0%
|
15.9 |
29,831
|
Common Stock |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
20 Apr 2021 |
2,227 |
86,092
|
-
|
|
-
|
Stock Option (right to buy) |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
20 Apr 2021 |
1,875 |
14,057
|
-
|
|
-
|
Stock Option (right to buy) |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.51 per share. |
20 Apr 2021 |
1,875 |
33,319
(0%)
|
0%
|
3.5 |
6,581
|
Common Stock |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.16 per share. |
20 Apr 2021 |
2,227 |
33,671
(0%)
|
0%
|
6.2 |
13,718
|
Common Stock |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.16 per share. |
22 Mar 2021 |
2,227 |
33,671
(0%)
|
0%
|
6.2 |
13,718
|
Common Stock |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.51 per share. |
22 Mar 2021 |
1,874 |
33,318
(0%)
|
0%
|
3.5 |
6,578
|
Common Stock |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Sale of securities on an exchange or to another person at price $ 17.50 per share. |
22 Mar 2021 |
1,874 |
31,444
(0%)
|
0%
|
17.5 |
32,795
|
Common Stock |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.16 per share. |
22 Mar 2021 |
2,227 |
33,671
(0%)
|
0%
|
6.2 |
13,718
|
Common Stock |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Sale of securities on an exchange or to another person at price $ 17.50 per share. |
22 Mar 2021 |
2,227 |
31,444
(0%)
|
0%
|
17.5 |
38,973
|
Common Stock |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.51 per share. |
22 Mar 2021 |
1,875 |
33,319
(0%)
|
0%
|
3.5 |
6,581
|
Common Stock |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Sale of securities on an exchange or to another person at price $ 17.50 per share. |
22 Mar 2021 |
1,875 |
31,444
(0%)
|
0%
|
17.5 |
32,813
|
Common Stock |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Sale of securities on an exchange or to another person at price $ 17.50 per share. |
22 Mar 2021 |
2,227 |
31,444
(0%)
|
0%
|
17.5 |
38,973
|
Common Stock |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
22 Mar 2021 |
1,874 |
17,807
|
-
|
|
-
|
Stock Option (right to buy) |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
22 Mar 2021 |
2,227 |
90,546
|
-
|
|
-
|
Stock Option (right to buy) |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
22 Mar 2021 |
1,875 |
15,932
|
-
|
|
-
|
Stock Option (right to buy) |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
22 Mar 2021 |
2,227 |
88,319
|
-
|
|
-
|
Stock Option (right to buy) |
|
Allene Diaz
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Mar 2021 |
39,275 |
39,275
|
-
|
|
-
|
Stock Option (right to buy) |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
22 Feb 2021 |
2,227 |
92,773
|
-
|
|
-
|
Stock Option (right to buy) |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
22 Feb 2021 |
1,875 |
19,681
|
-
|
|
-
|
Stock Option (right to buy) |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
22 Feb 2021 |
2,227 |
95,000
|
-
|
|
-
|
Stock Option (right to buy) |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
22 Feb 2021 |
1,874 |
21,556
|
-
|
|
-
|
Stock Option (right to buy) |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Sale of securities on an exchange or to another person at price $ 20.01 per share. |
22 Feb 2021 |
2,227 |
31,444
(0%)
|
0%
|
20.0 |
44,562
|
Common Stock |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.16 per share. |
22 Feb 2021 |
2,227 |
33,671
(0%)
|
0%
|
6.2 |
13,718
|
Common Stock |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Sale of securities on an exchange or to another person at price $ 20.01 per share. |
22 Feb 2021 |
1,875 |
31,444
(0%)
|
0%
|
20.0 |
37,519
|
Common Stock |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.51 per share. |
22 Feb 2021 |
1,875 |
33,319
(0%)
|
0%
|
3.5 |
6,581
|
Common Stock |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Sale of securities on an exchange or to another person at price $ 20.01 per share. |
22 Feb 2021 |
2,227 |
31,444
(0%)
|
0%
|
20.0 |
44,562
|
Common Stock |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.16 per share. |
22 Feb 2021 |
2,227 |
33,671
(0%)
|
0%
|
6.2 |
13,718
|
Common Stock |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.51 per share. |
22 Feb 2021 |
1,874 |
33,318
(0%)
|
0%
|
3.5 |
6,578
|
Common Stock |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Sale of securities on an exchange or to another person at price $ 20.01 per share. |
22 Feb 2021 |
1,874 |
31,444
(0%)
|
0%
|
20.0 |
37,499
|
Common Stock |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Sale of securities on an exchange or to another person at price $ 21.54 per share. |
20 Jan 2021 |
1,874 |
31,444
(0%)
|
0%
|
21.5 |
40,366
|
Common Stock |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
20 Jan 2021 |
2,227 |
97,227
|
-
|
|
-
|
Stock Option (right to buy) |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
20 Jan 2021 |
1,875 |
23,430
|
-
|
|
-
|
Stock Option (right to buy) |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
20 Jan 2021 |
2,227 |
99,454
|
-
|
|
-
|
Stock Option (right to buy) |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
20 Jan 2021 |
1,874 |
25,305
|
-
|
|
-
|
Stock Option (right to buy) |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Sale of securities on an exchange or to another person at price $ 21.54 per share. |
20 Jan 2021 |
2,227 |
31,444
(0%)
|
0%
|
21.5 |
47,970
|
Common Stock |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.16 per share. |
20 Jan 2021 |
2,227 |
33,671
(0%)
|
0%
|
6.2 |
13,718
|
Common Stock |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Sale of securities on an exchange or to another person at price $ 21.54 per share. |
20 Jan 2021 |
1,875 |
31,444
(0%)
|
0%
|
21.5 |
40,388
|
Common Stock |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.51 per share. |
20 Jan 2021 |
1,875 |
33,319
(0%)
|
0%
|
3.5 |
6,581
|
Common Stock |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Sale of securities on an exchange or to another person at price $ 21.54 per share. |
20 Jan 2021 |
2,227 |
31,444
(0%)
|
0%
|
21.5 |
47,970
|
Common Stock |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.16 per share. |
20 Jan 2021 |
2,227 |
33,671
(0%)
|
0%
|
6.2 |
13,718
|
Common Stock |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.51 per share. |
20 Jan 2021 |
1,874 |
33,318
(0%)
|
0%
|
3.5 |
6,578
|
Common Stock |
|
Anna Protopapas
|
Director, President & CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.09 per share. |
15 Jan 2021 |
5,198 |
224,922
(0%)
|
0%
|
21.1 |
109,626
|
Common Stock |
|
Anna Protopapas
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jan 2021 |
85,000 |
85,000
|
-
|
|
-
|
Restricted Stock Units |
|
Anna Protopapas
|
Director, President & CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Jan 2021 |
17,709 |
230,120
(0%)
|
0%
|
|
-
|
Common Stock |
|
Anna Protopapas
|
Director, President & CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Jan 2021 |
17,709 |
53,124
|
-
|
|
-
|
Restricted Stock Units |
|
Anna Protopapas
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jan 2021 |
382,500 |
382,500
|
-
|
|
-
|
Stock Option (right to buy) |
|
Kristen M. Hege
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jan 2021 |
2,547 |
2,547
|
-
|
|
-
|
Stock Option (right to buy) |
|
Willard H. Dere
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jan 2021 |
3,141 |
3,141
|
-
|
|
-
|
Stock Option (right to buy) |
|
David M. Mott
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jan 2021 |
4,528 |
4,528
|
-
|
|
-
|
Stock Option (right to buy) |
|
Lawrence M. Alleva
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jan 2021 |
3,339 |
3,339
|
-
|
|
-
|
Stock Option (right to buy) |
|
Martin H. Huber
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jan 2021 |
2,490 |
2,490
|
-
|
|
-
|
Stock Option (right to buy) |
|
Andrew A. F. Hack
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jan 2021 |
2,971 |
2,971
|
-
|
|
-
|
Stock Option (right to buy) |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jan 2021 |
29,167 |
29,167
|
-
|
|
-
|
Restricted Stock Units |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jan 2021 |
131,250 |
131,250
|
-
|
|
-
|
Stock Option (right to buy) |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Jan 2021 |
7,917 |
23,750
|
-
|
|
-
|
Restricted Stock Units |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.09 per share. |
15 Jan 2021 |
2,324 |
31,444
(0%)
|
0%
|
21.1 |
49,013
|
Common Stock |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Jan 2021 |
7,917 |
33,768
(0%)
|
0%
|
|
-
|
Common Stock |
|
Michael Kaufman
|
Sr VP, Chemistry, Man.&Control |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jan 2021 |
25,000 |
25,000
|
-
|
|
-
|
Restricted Stock Units |
|
Michael Kaufman
|
Sr VP, Chemistry, Man.&Control |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Jan 2021 |
6,667 |
6,667
(0%)
|
0%
|
|
-
|
Common Stock |
|
Michael Kaufman
|
Sr VP, Chemistry, Man.&Control |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.09 per share. |
15 Jan 2021 |
1,957 |
4,710
(0%)
|
0%
|
21.1 |
41,273
|
Common Stock |
|
Michael Kaufman
|
Sr VP, Chemistry, Man.&Control |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Jan 2021 |
6,667 |
20,000
|
-
|
|
-
|
Restricted Stock Units |
|
Michael Kaufman
|
Sr VP, Chemistry, Man.&Control |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jan 2021 |
112,500 |
112,500
|
-
|
|
-
|
Stock Option (right to buy) |
|
Brian DeSchuytner
|
Sr. VP., FIN, Product Strategy |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jan 2021 |
25,000 |
25,000
|
-
|
|
-
|
Restricted Stock Units |
|
Brian DeSchuytner
|
Sr. VP., FIN, Product Strategy |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Jan 2021 |
3,959 |
7,585
(0%)
|
0%
|
|
-
|
Common Stock |
|
Brian DeSchuytner
|
Sr. VP., FIN, Product Strategy |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.09 per share. |
15 Jan 2021 |
1,162 |
6,423
(0%)
|
0%
|
21.1 |
24,507
|
Common Stock |
|
Brian DeSchuytner
|
Sr. VP., FIN, Product Strategy |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Jan 2021 |
3,959 |
11,874
|
-
|
|
-
|
Restricted Stock Units |
|
Brian DeSchuytner
|
Sr. VP., FIN, Product Strategy |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jan 2021 |
112,500 |
112,500
|
-
|
|
-
|
Stock Option (right to buy) |
|
Ashish Mandelia
|
VP, Controller |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.09 per share. |
15 Jan 2021 |
289 |
545
(0%)
|
0%
|
21.1 |
6,095
|
Common Stock |
|
Ashish Mandelia
|
VP, Controller |
Sale of securities on an exchange or to another person at price $ 21.28 per share. |
15 Jan 2021 |
545 |
0
(0%)
|
0%
|
21.3 |
11,598
|
Common Stock |
|
Ashish Mandelia
|
VP, Controller |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Jan 2021 |
834 |
834
(0%)
|
0%
|
|
-
|
Common Stock |
|
Ashish Mandelia
|
VP, Controller |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jan 2021 |
18,077 |
18,077
|
-
|
|
-
|
Restricted Stock Units |
|
Ashish Mandelia
|
VP, Controller |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jan 2021 |
27,115 |
27,115
|
-
|
|
-
|
Stock Option (right to buy) |
|
Ashish Mandelia
|
VP, Controller |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Jan 2021 |
834 |
2,499
|
-
|
|
-
|
Restricted Stock Units |
|
Andrew A. F. Hack
|
Director |
Purchase of securities on an exchange or from another person at price $ 18.52 per share. |
08 Jan 2021 |
75,000 |
3,620,667
(7%)
|
0%
|
18.5 |
1,389,000
|
Common Stock |
|
Andrew A. F. Hack
|
Director |
Purchase of securities on an exchange or from another person at price $ 18.39 per share. |
08 Jan 2021 |
100,000 |
3,545,667
(7%)
|
0%
|
18.4 |
1,839,000
|
Common Stock |
|
Andrew A. F. Hack
|
Director |
Purchase of securities on an exchange or from another person at price $ 18.16 per share. |
08 Jan 2021 |
75,000 |
3,695,667
(8%)
|
0%
|
18.2 |
1,362,000
|
Common Stock |
|
Ashish Mandelia
|
VP, Controller |
Sale of securities on an exchange or to another person at price $ 26.76 per share. |
04 Jan 2021 |
247 |
0
(0%)
|
0%
|
26.8 |
6,610
|
Common Stock |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.40 per share. |
28 Dec 2020 |
9,000 |
25,851
(0%)
|
0%
|
1.4 |
12,600
|
Common Stock |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
28 Dec 2020 |
9,000 |
65,593
|
-
|
|
-
|
Stock Option (right to buy) |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
21 Dec 2020 |
1,875 |
27,179
|
-
|
|
-
|
Stock Option (right to buy) |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
21 Dec 2020 |
2,227 |
103,908
|
-
|
|
-
|
Stock Option (right to buy) |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
21 Dec 2020 |
1,874 |
29,054
|
-
|
|
-
|
Stock Option (right to buy) |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Sale of securities on an exchange or to another person at price $ 25.60 per share. |
21 Dec 2020 |
2,227 |
0
(0%)
|
0%
|
25.6 |
57,011
|
Common Stock |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.16 per share. |
21 Dec 2020 |
2,227 |
2,227
(0%)
|
0%
|
6.2 |
13,718
|
Common Stock |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Sale of securities on an exchange or to another person at price $ 25.60 per share. |
21 Dec 2020 |
1,875 |
0
(0%)
|
0%
|
25.6 |
48,000
|
Common Stock |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.51 per share. |
21 Dec 2020 |
1,875 |
1,875
(0%)
|
0%
|
3.5 |
6,581
|
Common Stock |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Sale of securities on an exchange or to another person at price $ 25.59 per share. |
21 Dec 2020 |
2,227 |
0
(0%)
|
0%
|
25.6 |
56,989
|
Common Stock |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.16 per share. |
21 Dec 2020 |
2,227 |
2,227
(0%)
|
0%
|
6.2 |
13,718
|
Common Stock |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.51 per share. |
21 Dec 2020 |
1,874 |
1,874
(0%)
|
0%
|
3.5 |
6,578
|
Common Stock |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Sale of securities on an exchange or to another person at price $ 25.59 per share. |
21 Dec 2020 |
1,874 |
0
(0%)
|
0%
|
25.6 |
47,956
|
Common Stock |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
21 Dec 2020 |
2,227 |
101,681
|
-
|
|
-
|
Stock Option (right to buy) |
|
David M. Mott
|
Director |
Other type of transaction at price $ 0.00 per share. |
14 Dec 2020 |
486 |
9,595
(0%)
|
0%
|
|
0
|
Common Stock |
|
David M. Mott
|
Director |
Other type of transaction at price $ 0.00 per share. |
14 Dec 2020 |
1,096 |
9,109
(0%)
|
0%
|
|
0
|
Common Stock |
|
David M. Mott
|
Director |
Other type of transaction at price $ 0.00 per share. |
01 Dec 2020 |
496 |
8,013
(0%)
|
0%
|
|
0
|
Common Stock |
|
David M. Mott
|
Director |
Other type of transaction at price $ 0.00 per share. |
01 Dec 2020 |
1,117 |
7,517
(0%)
|
0%
|
|
0
|
Common Stock |
|
Arvin Yang
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Nov 2020 |
37,000 |
37,000
|
-
|
|
-
|
Restricted stock unit |
|
Arvin Yang
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Nov 2020 |
200,000 |
200,000
|
-
|
|
-
|
Stock Option (right to buy) |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Sale of securities on an exchange or to another person at price $ 23.06 per share. |
20 Nov 2020 |
1,874 |
0
(0%)
|
0%
|
23.1 |
43,214
|
Common Stock |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
20 Nov 2020 |
2,227 |
106,135
|
-
|
|
-
|
Stock Option (right to buy) |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
20 Nov 2020 |
1,875 |
30,928
|
-
|
|
-
|
Stock Option (right to buy) |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
20 Nov 2020 |
2,227 |
108,362
|
-
|
|
-
|
Stock Option (right to buy) |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
20 Nov 2020 |
1,874 |
32,803
|
-
|
|
-
|
Stock Option (right to buy) |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Sale of securities on an exchange or to another person at price $ 23.04 per share. |
20 Nov 2020 |
2,227 |
0
(0%)
|
0%
|
23.0 |
51,310
|
Common Stock |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.16 per share. |
20 Nov 2020 |
2,227 |
2,227
(0%)
|
0%
|
6.2 |
13,718
|
Common Stock |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Sale of securities on an exchange or to another person at price $ 23.04 per share. |
20 Nov 2020 |
1,875 |
0
(0%)
|
0%
|
23.0 |
43,200
|
Common Stock |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.51 per share. |
20 Nov 2020 |
1,875 |
1,875
(0%)
|
0%
|
3.5 |
6,581
|
Common Stock |
|
Timothy B. Lowinger
|
Chief Science & Tech. Officer |
Sale of securities on an exchange or to another person at price $ 23.06 per share. |
20 Nov 2020 |
2,227 |
0
(0%)
|
0%
|
23.1 |
51,355
|
Common Stock |